Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-CIK Combined With Chemotherapy for NSCLC
NCT02651441Phase 2Unknown
- Sponsor
- Shenzhen Hornetcorn Biotechnology Co., Ltd.
- Start
- Feb 2016
- Primary completion
- May 2019
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of dendritic cell vaccine + cytokine-induced killer cells in non-small cell lung cancer (NSCLC), sponsored by Shenzhen Hornetcorn Biotechnology Co., Ltd.. Status: unknown.
02
Drugs
dendritic cell vaccine + cytokine-induced killer cells
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02651441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02651441.